← Back to Search

Behavioral Intervention

Vivo for Prediabetes

N/A
Recruiting
Research Sponsored by Impactiv, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 60 years
Low functioning: 1) able to do at least 1 chair stand and 2) number of chair stands done in 30 seconds is below criterion-referenced fitness standards for maintaining physical independence for age and gender
Must not have
Inability to complete physical function assessment
Lower extremity amputation or paralysis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 weeks
Awards & highlights

Summary

"This trial will last for 12 weeks and will look at how Vivo affects lower body strength and blood sugar levels compared to doing nothing."

Who is the study for?
This trial is for older adults who are not very active and have prediabetes, a condition where blood sugar levels are higher than normal but not high enough to be type 2 diabetes. They should be experiencing muscle weakness or loss due to aging.
What is being tested?
The study tests Vivo's effects on physical function, specifically leg strength measured by the number of chair stands in half a minute, and its impact on blood sugar control as indicated by HbA1c levels over a period of 12 weeks compared to those who wait for treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I can do at least one chair stand but less than the age/gender standard in 30 seconds.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot complete physical function tests.
Select...
I have had an amputation or paralysis in my lower body.
Select...
I am using testosterone supplements.
Select...
I do not have unstable heart conditions or uncontrolled high blood pressure.
Select...
I have an active cancer that is not a non-melanoma skin cancer.
Select...
I am unable to give my consent.
Select...
I am on hemodialysis for end-stage kidney disease.
Select...
I have a brain condition that affects my thinking or physical abilities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Lower body strength
Secondary outcome measures
Aerobic Endurance
Balance
Hemoglobin A1C (HbA1C)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Vivo interventionExperimental Treatment1 Intervention
Participants will meet virtually twice a week for 12 weeks with their small group and certified trainer for 45 minutes.
Group II: Waitlist controlActive Control1 Intervention
Participants randomized to this arm will be asked to maintain their baseline physical activity for 12-weeks. They will be scheduled for the baseline and 12-week assessment and following the 12-week assessment, they will be offered enrollment into Vivo.

Find a Location

Who is running the clinical trial?

Impactiv, Inc.Lead Sponsor
1 Previous Clinical Trials
334 Total Patients Enrolled
Duke UniversityOTHER
2,424 Previous Clinical Trials
3,065,994 Total Patients Enrolled
~60 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top